Activity of systemic therapies after cabozantinib (CABO) in patients (pts) with metastatic renal cell carcinoma (mRCC)

被引：1
|
作者：
Cerbone, L. [1 ]
Di Nunno, V. [2 ]
Carril, L. [1 ]
Benchimol-Zouari, A. [1 ]
Flippot, R. [1 ]
Silva, C. Alves Costa [1 ]
Colomba-Blameble, E. [1 ]
Guida, A. [3 ]
Derosa, L. [1 ]
Escudier, B. [1 ]
Albiges, L. [1 ]
机构：
[1] Inst Gustave Roussy, Dept Med Oncol, Villejuif, France
[2] Osped Bellaria, Oncol Med, Bologna, Italy
[3] Osped Santa Chiara Terni, Med & Traslat Oncol, Terni, Italy
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.815
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
743P
引用
收藏
页码：S577 / S577
页数：1
相关论文
共 50 条
  • [21] Outcomes of patients (pts) with metastatic renal cell carcinoma (mRCC) treated with pazopanib after progression on other targeted therapies (TT): Updated results
    Matrana, Marc Ryan
    Duran, Cihan
    Shetty, Aditya
    Xiao, Lianchun
    Atkinson, Bradley J.
    Corn, Paul G.
    Charnsangavej, Chusilp
    Jonasch, Eric
    Tannir, Nizar M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [22] Prognostic impact of lymphnode metastasis in patients (pts) with metastatic renal cell carcinoma (mRCC)
    Ivanyi, P.
    Tiemann, M. -L.
    Eggers, H.
    Reuter, C.
    Peters, I.
    Kuczyk, M.
    Ganser, A.
    Gruenwald, V.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 80 - 80
  • [23] Efficacy and safety of everolimus in elderly patients (pts) with metastatic renal cell carcinoma (mRCC)
    Osanto, S.
    Hutson, T. E.
    Calvo, E.
    Escudier, B. J.
    Oudard, S.
    Porta, C.
    Bracarda, S.
    Grunwald, V.
    Ravaud, A.
    Motzer, R. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [24] Outcome of patients (pts) with metastatic renal cell carcinoma (mRCC) treated with systemic therapy without cytoreductive nephrectomy (CN)
    Richey, S. L.
    Culp, S. H.
    Wood, C. G.
    Corn, P. G.
    Jonasch, E.
    Tannir, N. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [25] IMPACT OF ADVERSE DRUG REACTIONS (ADR) ON SYSTEMIC THERAPY IN PATIENTS (PTS) WITH ADVANCED OR METASTATIC RENAL CELL CARCINOMA (MRCC)
    Marschner, N.
    Muench, A.
    Sauer, U.
    Blumenstengel, K.
    Mueller, L.
    ANNALS OF ONCOLOGY, 2010, 21 : 298 - 298
  • [26] Clinical outcomes in metastatic renal cell carcinoma (mRCC) treated with combination of nivolumab and cabozantinib (nivo-cabo) in the salvage setting.
    Ravindranathan, Deepak
    Liu, Yuan
    Martini, Dylan J.
    Nazha, Bassel
    Brown, Jacqueline T.
    Russler, Greta
    Yantorni, Lauren Beth
    Caulfield, Sarah
    Master, Viraj A.
    Carthon, Bradley Curtis
    Kucuk, Omer
    Bilen, Mehmet Asim
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [27] Effect of CBM588 in combination with cabozantinib plus nivolumab for patients (pts) with metastatic renal cell carcinoma (mRCC): A randomized clinical trial
    Ebrahimi, Hedyeh
    Meza, Luis A.
    Lee, Keehoon
    Malhotra, Jasnoor
    Alcantara, Marice
    Zengin, Zeynep Busra
    Dizman, Nazli
    Govindarajan, Ameish
    Hsu, Joann
    Llamas-Quitiquit, Marian
    Chawla, Neal Shiv
    Castro, Daniela V.
    Mercier, Benjamin D.
    Liu, Sandy
    Chehrazi-Raffle, Alex
    Dorff, Tanya B.
    Frankel, Paul Henry
    Li, Xiaochen
    Pal, Sumanta Kumar
    Tripathi, Abhishek
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (17_SUPPL) : LBA104 - LBA104
  • [28] Renal safety of sunitinib treatment: A prospective study for patients (pts) with metastatic renal cell carcinoma (mRCC)
    Billemont, B.
    Rixe, O.
    Meric, J. B.
    Alexandre, J.
    Goldwasser, F.
    Izzedine, H.
    ANNALS OF ONCOLOGY, 2008, 19 : 36 - 36
  • [29] Sexual Disorders of Patients With Metastatic Renal Cell Carcinoma (mRCC) Treated With Antiangiogenic Therapies
    Denouel, Angeline
    Heutte, Natacha
    Escudier, Bernard
    Kurtz, Jean-Emmanuel
    Dos Santos, Melanie
    Longato, Nadine
    Desrues, Laurence
    Dauchy, Sarah
    Lange, Marie
    Sevin, Emmanuel
    Rieux, Chantal
    Clarisse, Benedicte
    Castel, Helene
    Noal, Sabien
    Joly, Florence
    CLINICAL GENITOURINARY CANCER, 2018, 16 (05) : 369 - +
  • [30] Outcome of metastatic renal cell carcinoma (mRCC) patients in the era of new targeted therapies
    Ruiz, A. L.
    Bolos, M. V.
    Viqueira, A.
    Esteban, E.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S654 - S654
12345